849934-94-7

Basic information

• Product Name: Methyl 2-(4-broMo-2-chlorophenyl)acetate
• Synonyms: Methyl 2-(4-broMo-2-chlorophenyl)acetate;(4-Bromo-2-chlorophenyl)aceticacidmethylester
• CAS NO: 849934-94-7
• Molecular Formula: C₉H₈BrClO₂
• Molecular Weight: 263.51562
• EINECS: -0
• Mol File: 849934-94-7.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 297.7±25.0 °C(Predicted)
• Appearance: /
• Density: 1.546±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 2-(4-broMo-2-chlorophenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-(4-broMo-2-chlorophenyl)acetate(849934-94-7)
• EPA Substance Registry System: Methyl 2-(4-broMo-2-chlorophenyl)acetate(849934-94-7)

Safety Data

• Hazardous Substances Data: 849934-94-7(Hazardous Substances Data)

Usage

General Description

Methyl 2-(4-bromo-2-chlorophenyl)acetate is a chemical compound that belongs to the class of acetate esters. It is a derivative of acetic acid and contains a methyl group and an aromatic ring with bromine and chlorine substituents. Methyl 2-(4-broMo-2-chlorophenyl)acetate is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various pharmaceutical drugs and agrochemicals. It is known for its potential biological activities and is used as an intermediate in the manufacturing of many bioactive molecules. Its unique structure and properties make it an important chemical for various industrial and research applications.

Upstream product

• 67197-54-0 2-(4-bromo-2-chlorophenyl)acetonitrile 
• 916516-89-7 2-(4-bromo-2-chlorophenyl)acetic acid 
• 74-88-4 methyl iodide 
• 89794-02-5 4-bromo-2-chlorotoluene 
• 89720-77-4 4-bromo-1-bromomethyl-2-chlorobenzene 
• 67-56-1 methanol 
• 59748-90-2 4-Bromo-2-chloro-benzoic Acid 
• 185315-48-4 (4-bromo-2-chlorophenyl)methanol 
• 31928-47-9 4-bromo-2-chloroiodobenzene 
• 53429-22-4 methyl 2-bromozincacetate 
• 75-36-5 acetyl chloride 

Downstream Products

• 849934-95-8 methyl 2-(2-chloro-4-(1,1,2,2-tetramethyl-1λ4,2λ4,4-dioxaborolan-4-yl)phenyl)acetate 
• 916516-90-0 2-(4-bromo-2-chlorophenyl)ethyl alcohol 
• 1428761-08-3 methyl 2-(2-chloro-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)acetate 
• 1428761-07-2 methyl 2-(2-chloro-4-(N-hydroxycarbamimidoyl)phenyl)acetate 
• 1428761-21-0 methyl 2-(2-chloro-4-(2-methylthiazol-5-yl)phenyl)acetate 
• 1432909-78-8 methyl 2-(2-chloro-4-(2-fluoropyridin-3-yl)phenyl)acetate 
• 1261501-82-9 methyl 2-(2-chloro-4-cyanophenyl)acetate 
• 1428761-22-1 methyl 2-(2-chloro-4-(2-methyloxazol-5-yl)phenyl)acetate 
• 1433193-87-3 2-chloro-6-(2-chloro-4-(6-methylpyrazin-2-yl)phenyl)-8-ethylpyrido[2,3-d]pyrimidin-7(8H)-one 
• 1432908-05-8 6-(2-chloro-4-(6-methylpyrazin-2-yl)phenyl)-8-ethyl-2-((2-(1-methylpiperidin-4-yl)ethyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one 

Relevant articles and documents

Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists

GSK805 (1) is a potent RORγt inverse agonist, but a drawback of 1 is its low solubility, leading to a limited absorption in high doses. We have explored detailed structure-activity relationship on the amide linker, biaryl and arylsulfonyl moieties of 1 trying to improve solubility while maintaining RORγt activity. As a result, a novel series of carboxyl-containing biaryl urea derivatives was discovered as potent RORγt inverse agonists with improved drug-like properties. Compound 3i showed potent RORγt inhibitory activity and subtype selectivity with an IC50 of 63.8 nM in RORγ FRET assay and 85 nM in cell-based RORγ-GAL4 promotor reporter assay. Reasonable inhibitory activity of 3i was also achieved in mouse Th17 cell differentiation assay (76percent inhibition at 0.3 μM). Moreover, 3i had greatly improved aqueous solubility at pH 7.4 compared to 1, exhibited decent mouse PK profile and demonstrated some in vivo efficacy in an imiquimod-induced psoriasis mice model.

An optimized synthesis of the potent and selective Pak1 inhibitor FRAX-1036

FRAX-1036 is a p21-activated kinase I inhibitor of significant interest to cancer biologists yet no commercial providers or detailed procedures are available. In this Letter, we chronicle the optimized synthesis of FRAX-1036, one of the most specific Pak1